Business Investment Opportunities

The company is a pan-India organization with a vision of achieving INR 100 crores turnover in the next 5 years, reflecting its ambitious growth plans in the Pharma Marketing industry. - The company's portfolio includes brands in the pediatric neurology and pediatric gastroenterology segments, focused on providing innovative clinical nutrition products. Currently, the sales team is actively engaged in meeting super specialist doctors across the country to promote these products. - With a presence in Aurangabad, the company operates from a rental office and has a godown at Kalher, Bhiwandi, and warehouses spread across the country from Srinagar to Kanyakumari, demonstrating its extensive distribution network. - The company has established tie-ups with over 100 stockists/distributors in various regions, showcasing a well-connected supply chain network. - Over the last 10 months, the company has successfully engaged more than 300 doctors who are prescribing its brands, indicating a positive reception of its products within the medical community. - The owner brings 13 years of industry experience and has a significant achievement of being the first CEO in 105 years to speak at the ICMR from a non-medical background, underscoring his expertise and leadership in the field. - We started operations in July last year and are looking to complete our first entire calendar year of operations this year. - We have all the required certifications to function.

The company specializes in manufacturing medium and small-sized fiberglass boats, aluminum boats, steel tugs, barges, and dredgers. - We also have a dealership with Honda and supply OBM engines. - The company holds certifications such as ISO 9001:2015, ROHS, IAF, DAC, and is an IACS-approved yard by the Indian Register of Shipping. - We also hold the government approved ship building license, which bestows the right to manufacture ships within the country, - It operates a state-of-the-art manufacturing facility in Cuddalore, Tamil Nadu, and offers sales and after-sales service support globally. - The managing partner brings over 15 years of industry experience, managing a team of 25 employees. - The company has a strong focus on the Indian market but also exports to the MENA region. - We enjoy repeat business mainly from government bodies.

Supermarket chain in Kottayam with 5 retail outlets. - Operating various formats including hypermarkets, supermarkets, and express markets, catering to diverse consumer needs. - Boasting a strong local presence with over 250,000 loyal customers, indicating robust brand loyalty and market penetration. - Currently operating five outlets within a 50-kilometer radius, with plans to expand by adding two more stores in the current financial year, showcasing a commitment to growth and scalability. - Investors will receive a stake in the private limited company that owns and operates the supermarkets, ensuring transparency and legal compliance. - Promoters bring in a collective experience of six years in the supermarket industry, offering valuable insights and expertise in business operations and management. - Engages with a network of 250 suppliers, ensuring a diverse range of products and maintaining strong supplier relationships. - Holds necessary licenses including GST and FSSAI, demonstrating compliance with regulatory standards and ensuring the quality and safety of products offered. - Each of our stores is meticulously crafted as air-conditioned convenience outlets, offering a curated selection of both local and international products, enhancing the overall shopping journey for our customers.

Supermarket chain in Kottayam with 5 retail outlets. - Operating various formats including hypermarkets, supermarkets, and express markets, catering to diverse consumer needs. - Boasting a strong local presence with over 250,000 loyal customers, indicating robust brand loyalty and market penetration. - Currently operating five outlets within a 50-kilometer radius, with plans to expand by adding two more stores in the current financial year, showcasing a commitment to growth and scalability. - Investors will receive a stake in the private limited company that owns and operates the supermarkets, ensuring transparency and legal compliance. - Promoters bring in a collective experience of six years in the supermarket industry, offering valuable insights and expertise in business operations and management. - Engages with a network of 250 suppliers, ensuring a diverse range of products and maintaining strong supplier relationships. - Holds necessary licenses including GST and FSSAI, demonstrating compliance with regulatory standards and ensuring the quality and safety of products offered. - Each of our stores is meticulously crafted as air-conditioned convenience outlets, offering a curated selection of both local and international products, enhancing the overall shopping journey for our customers.

The company is a bio-medical startup based in Mumbai with a current manufacturing capacity of 20,000 units and is seeking investment to scale marketing, distribution, and assembly. - The heart rate monitor is the top-selling product, with an average of 200 units sold per month through online channels such as the company's website and Amazon. Revenue sources are diversified, with 40% of sales revenue coming from Amazon and 60% from the company's website. The company utilizes Ship Rocket and Amazon for logistics. - The company's current sales are entirely business-to-consumer (B2C) - The company has garnered interest from Bridge Health and Fitterfly for the use of its product in BP reduction programs, showcasing the potential for further B2B partnerships. - The heart rate monitor is currently sold at an introductory price of INR 1,999 for the first 1,000 devices, with the regular price set at INR 3,499. The company aims to sell approximately 1 lakh units by the end of the year. - The product current has a +/- 2 points tolerance, which shows they are 98% accurate. - Collaborating with telemedicine doctors. - The company has currently outsourced manufacturing with a manufacturing capacity of approximately 20,000 units manufactured a month and we have our own testing and assembly rigs to avoid any leaking of design and work. - The business already has a ready stock of more than 10,000 units in inventory and is sending them for testing to its partners. - The business holds the necessary GST certificate & an ISO 13485 certificate.

Top-selling products and services include cab aggregation, inter-city rides, ambulance bookings, chauffeur services, and vehicle leasing. These services cater to a wide range of users, from individuals seeking convenient transportation options to vehicle owners looking to lease their cars through the platform. Customers can easily access these services through the mobile app and website, providing a seamless and efficient way to book rides, ambulances, chauffeurs, and lease vehicles for various transportation needs. - A booking fee of ₹10 per booking is charged whenever users book any ride such as a bike, auto & car cab, inter-city cab, rentals, or ambulance booking through the app or website. - We expect to launch operations in the next 3 months, our app is under construction. - Promoters have 6 years of experience in running and managing similar businesses. - Legal compliance includes license incorporation and GST registration. - Company is operating from Noida, but registered in Hathras, UP.

Drug reformulation pharmaceutical company based in Los Angeles. - Focused on developing drugs through Phase I to IV to achieve FDA approval. - Primarily directed towards improving health outcomes in the neurosciences and beyond. - Dedicated to finding innovative and effective treatment solutions to the most challenging ailments related to the Central Nervous System. - This is done by transforming positive clinical results from decades of hands-on patient care experience into rigorous scientific research. - The company has 10 patented products in its portfolio, some of which have the potential to generate annual revenues ranging from $200 million to $1 billion per product. - 4 of these products need to be moved to Phase IIb. - The products cater to critical healthcare needs in America and are planned to be established through publication on popular channels to showcase the efficacy. - Also has a network of 70,000 pharmacies, providing a robust distribution platform for its products. - While the company owns the formulation of its products, the production is outsourced through external laboratories. - Led by 8 partners with over 100 years of combined professional experience in patient care, clinical research, and entrepreneurship. They bring vast experience in CNS-related drug development, ensuring a strong foundation for the company's operations.

We are an online casino business for the Indian market. - We are a B2C brand with over 100,000 registrations. - Revenue is charged by selling the casino tokens. - The development of the business has been done by a software company. - The software used is softgamings. - We require less employees as we are an online business. - Promoter has 12 years of experience in the online gaming industry. - Business is located in Curacau but the owner is in Thailand. - The business has the registration license to run an online business.

A biotech firm based in Milan, focusing on cancer immuno personalized therapy. - Has a portfolio of R&D projects and two Finished Dosage Forms (FDF) in the Italian market, including Aripiprazole and Emtricitabine + Tenofovir. - The company specializes in the development of microfluidic technology for the production and purification of Exosomes, with applications in anti-inflammatory, skin regenerative, anti-acne and atopic dermatitis, scalp rejuvenation, and hair growth treatments. - Exosomes, a key product of the company, are body-identical ingredients known for their high stability and low likelihood of causing adverse reactions. Their cell-penetrating mechanism enables them to deliver regeneration signals, making them suitable for diverse medical and cosmetic applications. - Has 3 major clients and supplied on a quarterly basis to pharmaceutical companies in Italy, Poland, and Brazil. - Operates with a network of 12 agents in addition to its 3 permanent employees. - Collaborates with Contract Manufacturing Organizations (CMOs) for the production of its pharmaceutical products. The company holds essential regulatory licenses from GMP, FDA, and the Ministry of Health, ensuring compliance with international quality and safety standards.